Click on the icon on the upper right hand side for the article by Eyal Shteyer, MD and Michael Wilschanski, MD.
IMAJ 2008: 11: November: 816-820
Abstract
Management of inflammatory bowel disease in childhood poses great challenges. Apart from the disease complications, the drugs' adverse affects, especially corticosteroids, are significant. In the past decade there was major progress in elucidating the pathogenesis of IBD, which led to new treatment options aiming to achieve better control of the disease and decrease the various complications of therapy currently used. In this review we provide an overview of novel therapies for IBD, their efficacy, safety and their current use in children.
Key words